$1.1B in expenses

Clinical care:fred hutch's focus is speeding the transfer of new diagnostic and treatment techniques from the research setting to patient care. The highly integrated approach to cancer research and treatment supports the flow of scientific information from researchers and the lab to clinicians and patients, thereby accelerating the development of new knowledge and treatment for various cancers. During the fiscal year, fred hutch had 3,727 patient days, 65,032 outpatient clinic visits, 95,774 infusion hours, 10,917 radiation oncology treatments, and performed 48,604 imaging scans. Our care teams served more than 63,000 patients in the fiscal year.as part of fred hutch's commitment to advancing the standard of cancer care, we offer many educational opportunities for health care professionals of all kinds seeking specialized knowledge in oncology settings to earn continuing education credits. Fred hutch is designated as an instructional site for bachelor and advanced degree candidates from several institutions around the puget sound area. Fred hutch education and training opportunities are available to people like providers and nurses, patients and caregivers, faculty, graduate students and postdoctoral and medical fellows. There are also internships and programs for secondary school teachers, as well as high school and undergraduate students. In fy24, there were approximately 300 trainees at fred hutch including graduate students and postdoctoral and clinical fellows.fred hutch offers temporary medical lodging facilities for patients and families while they receive active treatment at fred hutch. Their two available facilities are the behnke family house and the pete gross house. Lodging options can accommodate either short-term or long-term (30 night minimum) stays as medically necessary to keep patients close during their treatment at fred hutch. Fred hutch provides transportation to and from both facilities through the south lake union clinic.

$722.2M in expenses

Research program: fred hutch researchers have advanced human understanding across a wide range of areas, reflecting the breadth and depth of expertise at fred hutch that allows us to develop potential cures for cancer and infectious diseases. Our teams also applied artificial intelligence and other novel approaches to match existing treatments to diagnoses or better understand how cancer may be impacting individuals in different ways.fred hutch scientists are producing some of the most important breakthroughs in the prevention, early detection and treatment of cancer, HIV and other diseases. Our scientists study every aspect of the disease process to uncover factors that influence disease risk and progression. Fred hutch has been home to three nobel laureates, and our faculty includes more than 400 renowned researchers who collaborate with colleagues across the globe and mentor the next generation of scientific innovators. Our scientists conduct research on and develop therapies for many cancers including blood cancers and solid tumors as well as for HIV and other nonmalignant diseases. They study the disease process from every angle, from the most basic molecular and cellular levels to the population level. Their goals are to uncover the factors that influence a person's likelihood of developing and surviving a disease and use this knowledge to reduce risk, save lives and improve quality of life. Fred hutch researchers are experts in understanding the development of blood and solid tumor cancers as well as identifying new ways to diagnose, prevent and treat cancers. Their research includes a wide area of topics that affect cancer and infectious diseases such as behavioral research, cell and gene therapy, data science, disease prevention, health economics, virology, and more. In fy24, fred hutch researchers published 1,330 research articles and 48 patents were granted to fred hutch. Fred hutch research programs integrate the latest in computational, laboratory and patient-oriented clinical research methods to better understand the mechanisms that drive cancer and other human diseases. Our researchers are continually developing new therapeutic approaches and they develop and lead clinical trials that help move laboratory discoveries into new treatment options for patients. Our discoveries, which include proving that bone marrow transplantation can cure leukemias and other blood cancers, have saved more than a million lives worldwide.